Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Phase III data for Quadramet presented at ASCO

May 3, 1996

Zambon claims (S)-ibuprofen composition

May 3, 1996

Droxidopa studied in patients with chronic pain

May 3, 1996

MM-218 selected for development in emesis, diarrhea

April 26, 1996

Promising clinical results reported for CRF

April 26, 1996

NMDA/glycine-site antagonists revealed by RPR

April 26, 1996

Lilly claims mGluR antagonists for neurodegeneration

April 26, 1996

OPC-14523 improves learning in preclinical models

April 26, 1996

Mediolanum synthesizes AChE inhibitors for Alzheimer's

April 26, 1996

Scopolamine gel available in U.S. for motion sickness

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...